EleVation™ EVREFURB
EleVation EVREFURB is a mammographic stereotactic biopsy system (FDA Class II; FDA product code KNW, Instrument, Biopsy) made by Bard Peripheral Vascular, listed in FDA GUDID since 18 Jun 2020 (UDI-DI 00801741182464), registry data as of 22 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00801741182464 | Date18 Jun 2020 | StatusListed |
Official records
- AccessGUDID record 00801741182464
From the FDA record
- Device description
- EleVation™ Breast Biopsy System Driver Refurbished
- MRI safety
- MR Unsafe
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- EleVation™
- Generic name
- Mammographic stereotactic biopsy system
- Model / Ref / Catalog
- EVREFURB
- Primary DI / UDI-DI
- 00801741182464
- FDA product code
- KNW
- GMDN term
- Mammographic stereotactic biopsy system
- Device class
- Class II
- Regulation number
- 876.1075
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Unsafe
Similar devices in this category
Other devices filed under Mammographic stereotactic biopsy system.